FDA Approves New Pancreatic Cancer Treatment

Why it matters locally: The approval of this new pancreatic cancer treatment could offer a new option for patients and medical providers across North Carolina facing this aggressive disease.

U.S. health officials approved a new drug for pancreatic cancer. The Food and Drug Administration (FDA) announced the approval, which introduces a different method for treating the illness. The drug functions by blocking a protein that contributes to tumor growth. This protein is present in most pancreatic cancer cases. The new treatment targets this specific mechanism.